Work

Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors

Year: 2017

Type: article

Source: Hematology/Oncology Clinics of North America

DOI: 10.1016/j.hoc.2017.04.007

Authors: Ami B. Patel, Thomas O’Hare, Michael W. Deininger

Institutions: University of Utah, Huntsman Cancer Institute

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: V Foundation for Cancer Research, University of Utah, Hope Foundation, National Institutes of Health, National Cancer Institute

Awards: SIRT5 as a Therapeutic Target in Acute Myeloid Leukemia, G368171078, G4190287910, G9000281128

OpenAlex ID: W2729007679

FWCI: 9.941

Cites: 129

Cited by: 204

Related to: 10